Health care stocks were little changed with the Health Care Select Sector SPDR fund nearly flat.

Moderna shares posted one of their best gains in nearly two months as the vaccine developer said it advanced several pipeline candidates into late-stage clinical trials, including a next-generation Covid-19 vaccine. The drugmaker also announced up to $750 million in funding from Blackstone Life Sciences to help fund development for its flu program.

Pfizer said it would ask the Food and Drug Administration to expand the approval of its respiratory syncytial virus vaccine to include all adults over the age of 18.

Write to Patrick Sullivan at

(END) Dow Jones Newswires

04-09-24 1658ET